Orgenesis Inc. Purchase Agreements

14 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Asset Purchase and Strategic Collaboration Agreement, dated as of April 5, 2024, between Orgenesis Maryland LLC and Griffin Fund 3 BIDCO, Inc
Purchase Agreements
Orgenesis Inc.
2024
Securities Purchase Agreement, dated March 3, 2024, by and among the Company and the Investors
Purchase Agreements
Orgenesis Inc.
2024
Unit Purchase Agreement, dated as of January 29, 2024, between the Company and MM OS Holdings L.P
Purchase Agreements
Orgenesis Inc.
2024
Amendment Agreement, dated as of January 16, 2024, to Securities Purchase Agreement, dated November 8, 2023, by and among the Company and the November 2023 Investor
Purchase Agreements
Orgenesis Inc.
2024
Securities Purchase Agreement, dated August 31, 2023, by and among the Company and a certain investor
Purchase Agreements
Orgenesis Inc.
2023
Form of Securities Purchase Agreement, dated November 8, 2023, by and between Orgenesis Inc. and the Investor
Purchase Agreements
Orgenesis Inc.
2023
Securities Purchase Agreement, dated August 31, 2023, by and among the Company and the Investor
Purchase Agreements
Orgenesis Inc.
2023
Amendment No. 2 to Unit Purchase Agreement dated as of May 5, 2023 by and among Orgenesis Inc., Morgenesis LLC and MM OS Holdings, L.P
Purchase Agreements
Orgenesis Inc.
2023
Amendment No. 1 to Unit Purchase Agreement dated as of May 5, 2023 by and among Orgenesis Inc., Morgenesis LLC and MM OS Holdings, L.P
Purchase Agreements
Orgenesis Inc.
2023
Form of Securities Purchase Agreement between the Company and the Purchaser, dated February 23, 2023
Purchase Agreements
Orgenesis Inc.
Biotechnology
NY
2023
Unit Purchase Agreement dated as of November 4, 2022 by and among Orgenesis Inc., Morgenesis LLC and MM OS Holdings, L.P
Purchase Agreements
Orgenesis Inc.
Biotechnology
NV
2022
Securities Purchase Agreement, dated March 30, 2022, by and among the Company and the Investors
Purchase Agreements
Orgenesis Inc.
Biotechnology
NY
2022
Asset Purchase Agreement, dated April 12, 2020, by and between Orgenesis Inc., and Tamir Biotechnology, Inc
Purchase Agreements
Orgenesis Inc.
Biotechnology
NY
2020
Securities Purchase Agreement, dated January 20, 2020, by and among the Company and the Investors
Purchase Agreements
Orgenesis Inc.
Biotechnology
NY
2020